foxo4-dri senolytic 2023 2024 Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis Senotherapy for chronic lung disease
Senotherapy for chronic lung disease ScienceDirect Targeting Senescence: A Review of Senolytics and Senomorphics in Anti Aging Interventions FOXO4 DRI part 1 #peptide #molecule #research #health #information The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


